Skip to main navigation menu Skip to main content Skip to site footer
Plant Science Today (PST)

Research Articles

Vol. 12 No. Sp2 (2025): Current Trends in Plant Science and Microbiome for Sustainability

Medicinal plants potential as anti-mycobacterial and mechanisms behind their active metabolites

DOI
https://doi.org/10.14719/pst.4991
Submitted
8 September 2024
Published
08-06-2025

Abstract

Tuberculosis (TB) is a contagious disease caused by the bacterium Mycobacterium tuberculosis, which most often affects the lungs, specifically pulmonary tuberculosis. One of the leading opportunistic diseases globally, affecting one-third population and resulting in approximately 1.5 million deaths annually. A weakened immune system against mycobacterial diseases has contributed to over 1.1 million people being co-infected with other life-threatening diseases, such as Human Immunodeficiency Virus (HIV). Abundant research highlighted the biotherapeutic potential of naturally occurring compounds against mycobacterial disorder. The increasing cases of MDR/XDR-TB are mainly derived from tuberculosis, coupled with the emergence of extensively drug-resistant (XDR) and multidrug resistance (MDR) strains, have made treatment more challenging. The condition emphasized the crucial requirement for novel plant-derived anti-TB medications. The persistence and latency of M. tuberculosis, along with drug resistance, have made tuberculosis treatment increasingly challenging. This review aims to comprehensively examine tuberculosis disease including current standard treatment, promising new drugs under development and the potential of medicinal plants and their bioactive compounds as alternative or supplementary therapies to combat mycobacterial infections, specifically focusing on the potential of plant-derived metabolites to act as effective antimycobaterial agents. It specifically highlights the role of plant-derived metabolites as effective antimycobacterial agents.

References

  1. Nguta JM, Appiah-Opong R, Nyarko AK, Yeboah-Manu D, Addo PGA, Otchere ID, et al. In-vitro antimycobacterial and cytotoxic data on medicinal plants used to treat tuberculosis. Data Brief. 2016;7:1124–30. https://doi.org/10.1016/j.dib.2016.03.088
  2. Gupta VK, Kaushik A, Chauhan DS, Ahirwar RK, Sharma S, Bisht D. Anti-mycobacterial activity of some medicinal plants used traditionally by tribes from Madhya Pradesh, India for treating tuberculosis related symptoms. J Ethnopharmacol. 2018;227:113–20. https://doi.org/10.1016/j.jep.2018.08.031
  3. Mohamad S, Ismail NN, Parumasivam T, Ibrahim P, Osman HA, Wahab H. Antituberculosis activity, phytochemical identification of Costus speciosus (J. Koenig) Sm., Cymbopogon citratus (DC. Ex Nees) stapf., and Tabernaemontana coronaria (L.) wild. and their effects on the growth kinetics and cellular integrity of mycobacteria. BMC Complement Altern Med. 2018;18:5. https://doi.org/10.1186/s12906-017-2077-5
  4. Gemechu A, Giday M, Worku A, Ameni G. In-vitro anti-mycobacterial activity of selected medicinal plants against Mycobacterium tuberculosis and Mycobacterium bovis strains. BMC Complement Altern Med. 2013;13:291. https://doi.org/10.1186/1472-6882-13-291
  5. Jamkhande PG, Ghante MH, Barde SR, Ajgunde BR. Antimycobacterial, antimicrobial, antioxidant activities and in-silico pass investigations of root fractions and extract of Cordia dichotoma Forst. Orient Pharm Exp Med. 2019;19:485–96. https://doi.org/10.1007/s13596-019-00399-5
  6. Russo EB, Marcu J. Chapter Three - Cannabis pharmacology: the usual suspects and a few promising leads. Vol. 80: Adv Pharmacol Academic Press Inc; 2017. p. 67–134. https://doi.org/10.1016/bs.apha.2017.03.004
  7. Singh R, Hussain S, Verma R, Sharma P. Anti-mycobacterial screening of five Indian medicinal plants and partial purification of active extracts of Cassia sophera and Urtica dioica. Asian Pac J Trop Med. 2013;6:366–71. https://doi.org/10.1016/S1995-7645(13)60040-1
  8. Sharma P, Goyal RK, Nandave M. A review: prevention, treatment and management of tuberculosis through combinational approaches of different Indian systems of medicine. Drug Res (Stuttg). 2020;70:65–70. https://doi.org/10.1055/a-1078-1087
  9. Fernandez CMM, Baldin VP, Ieque AL, Bernuci KZ, Almeida RT, Valone LM, et al. Anti-mycobacterium tuberculosis activity of dichloromethane extract of Piper corcovadensis (Miq.) C. DC. roots and isolated compounds. Ind Crops Prod. 2019;131:341–47. https://doi.org/10.1016/j.indcrop.2019.01.064
  10. Nguta JM, Appiah-Opong R, Nyarko AK, Yeboah-Manu D, Addo PGA, Otchere ID, et al. In-vitro antimycobacterial activity and toxicity of eight medicinal plants against pathogenic and nonpathogenic mycobacterial strains. Vol. 5: In: Proceedings of the Int J Mycobacteriology; Elsevier Ltd, December; 2016. p. S106–07. https://doi.org/10.1016/j.ijmyco.
  11. 05.004
  12. Dey P, Kundu A, Kumar A, Gupta M, Lee BM, Bhakta T, et al. Analysis of alkaloids (indole alkaloids, isoquinoline alkaloids, tropane alkaloids). In: Recent Adv Nat Prod Anal; 2020. p. 505–67. https://doi.org/10.1016/b978-0-12-816455-6.00015-9
  13. Cushnie TP, Lamb AJ. Antimicrobial activity of flavonoids. Int J Antimicrob Agents. 2005;26(5):343–56. https://doi.org/10.1016/j.ijantimicag.2005.09.002
  14. Masyita A, Mustika SR, DwiAstuti A, Yasir B, RahmaRumata N, Emran Tb, et al. Terpenes and terpenoids as main bioactive compounds of essential oils, their roles in human health and potential application as natural food preservatives. Food Chem. 2022;13:100217. https://doi.org/10.1016/j.fochx.2022.100217
  15. Miklasi?ska-Majdanik M, K?pa M, Wojtyczka RD, Idzik D, W?sik TJ. Phenolic compounds diminish antibiotic resistance of Staphylococcus aureus clinical strains. IJERPH. 2018;15(10):2321. https://doi.org/10.3390/ijerph15102321
  16. Quémard A, Lacave C, Lanéelle G. Isoniazid inhibition of mycolic acid synthesis by cell extracts of sensitive and resistant strains of Mycobacterium aurum. Antimicrob Agents Chemother. 1991;35(6):1035–39. https://doi.org/10.
  17. /AAC.35.6.1035
  18. Campbell EA, Korzheva N, Mustaev A, Murakami K, Nair S, Goldfarb A, et al. Structural mechanism for rifampicin inhibition of bacterial RNA polymerase. Cell. 2001;104(6):901–12. https://doi.org/10.1016/s0092-8674(01)00286-0
  19. Goude R, Amin AG, Chatterjee D, Parish T. The arabinosyltransferaseEmbC is inhibited by ethambutol in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2009;53(10):4138–46. https://doi.org/10.1128/
  20. AAC.00162-09
  21. Garvin RT, Biswas DK, Gorini L. The effects of streptomycin or dihydrostreptomycin binding to 16S RNA or to 30S ribosomal subunits. Proc Natl Acad Sci USA. 1974;71(10):3814–18. https://doi.org/10.1073/pnas.71.10.3814
  22. Zhang Y, Shi W, Zhang W, Mitchison D. Mechanisms of pyrazinamide action and resistance. Microbiol Spectr. 2014;2(4):1–12. https://doi.org/10.1128/microbiolspec.MGM2-0023-2013
  23. Lin Y, Li Y, Zhu N, Han Y, Jiang W, Wang Y, et al. The antituberculosis antibiotic capreomycin inhibits protein synthesis by disrupting the interaction between ribosomal proteins L12 and L10. Antimicrob Agents Chemother. 2014;58(4):2038–44. https://doi.org/10.1128/AAC.02394-13
  24. Sagbo IJ, Hussein AA. Are plants used as a combating strategy against tuberculosis in the Mpumalanga province, South Africa? Appl Sci. 2023;13(8):5008. https://doi.org/10.3390/app13085008
  25. Zheng J, Rubin EJ, Bifani P, Mathys V, Lim V, Au M, et al. para-Aminosalicylic acid is a prodrug targeting dihydrofolate reductase in Mycobacterium tuberculosis. J Biol Chem. 2013;288(32):23447–56. https://doi.org/10.1074/jbc.M113.475798
  26. De Chiara C, Homšak M, Prosser GA, Douglas HL, Garza-Garcia A, Kelly G, et al. D-cycloserine destruction by alanine racemase and the limit of irreversible inhibition. Nat Chem Biol. 2020;16(6):686–94. https://doi.org/10.1038/
  27. s41589-020-0498-9
  28. North E J, Jackson M, Lee RE. New approaches to target the mycolic acid biosynthesis pathway for the development of tuberculosis therapeutics. Curr Pharm Des. 2021;20(27):4357–78. https://doi.org/10.2174/138161281
  29. Shams WE, Evans ME. Guide to selection of fluoroquinolones in patients with lower respiratory tract infections.
  30. Drugs. 2005;65(7):949–91. https://doi.org/10.2165/00003495-200565070-00004
  31. Field SK. Bedaquiline for the treatment of multidrug-resistant tuberculosis: great promise or disappointment? Ther Adv Chronic Dis. 2015;6(4):170–84. https://doi.org/10.1177/2040622315582325
  32. Khoshnood S, Taki E, Sadeghifard N, Kaviar VH, Haddadi MH, Farshadzadeh Z, et al. Mechanism of action, resistance, synergism, and clinical implications of delamanid against multidrug-resistant Mycobacterium tuberculosis. Front Microbiol. 2021;12:717045. https://doi.org/10.3389/fmicb.2021.717045
  33. Getachew S, Medhin G, Asres A, Abebe G, Ameni G. Traditional medicinal plants used in the treatment of tuberculosis in Ethiopia: A systematic review. Heliyon. 2022;8(5):e09478. https://doi.org/10.1016/j.heliyon.2022.e09
  34. Semenya SS, Maroyi A. Medicinal plants used for the treatment of tuberculosis by Bapedi traditional healers in three districts of the Limpopo Province, South Africa. Afr J Tradit Complement Altern Med. 2012;10(2):316–23. https://doi.org/10.4314/ajtcam.v10i2.17
  35. Gupta VK, Kumar MM, Bisht D, Kaushik A. Plants in our combating strategies against Mycobacterium tuberculosis: progress made and obstacles met. Pharm Biol. 2017;55(1):1536–44. https://doi.org/10.1080/13880209.2017.1309440
  36. Gautam S, Qureshi KA, Jameel PSB, Dhanasekaran S, Aspatwar A, Parkkila S, et al. Medicinal plants as therapeutic alternatives to combat Mycobacterium tuberculosis: A Comprehensive Review. Antibiotics. 2023;12(3):541. https://doi.org/10.3390/antibiotics12030541
  37. Dzoyem JP, Aro AO, McGaw LJ, Eloff JN. Antimycobacterial activity against different pathogens and selectivity index of fourteen medicinal plants used in southern Africa to treat tuberculosis and respiratory ailments. S Afr J Bot. 2016;102:70-74. ISSN 0254-6299. https://doi.org/10.1016/j.sajb.2015.08.002
  38. Xu Y, Liang B, Kong C, Sun Z. Traditional medicinal plants as a source of antituberculosis drugs: A system review. BioMed Res Int. 2021;9910365. https://doi.org/10.1155/2021/9910365

Downloads

Download data is not yet available.